Loading...

Home
ETF
MNKD

MNKD

-

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

Overview Technical News

Most Trusted AI Platform for Winning Trades

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

Home
Contact
About Us
Press
Privacy
Terms of Service
Service Terms of Use

Resources

Blog
Tutorial
Help Center
Affiliate Program

Markets

Market Analysis
Crypto
Featured Screeners
AI Earnings Calendar
Market Movers
Stock Monitor
Economic Calendar
All US Stocks
All Cryptos

Tools

Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator

Features

QuantAI Alpha Pick
SwingMax Portfolio
Swing Trading
AI Stock Picker
Whales Auto Tracker
Daytrading Center
Patterns Detection
AI Screener
Financial AI Agent
Backtesting Playground
AI Earnings Prediction
Stock Monitor
Technical Analysis

News

Overview
Top News
Daily Market Brief
Earnings Analysis
Newswire
Stock News
Crypto News
Institution News
Congress News
Monitor News

Compare

TradingView
SeekingAlpha

MNKD News

MannKind Corporation Showcases Growth Potential at Healthcare Conference

3d agoYahoo Finance

Avaí Bio Initiates Production of α-Klotho Cells

Mar 18 2026PRnewswire

Avaí Bio Initiates α-Klotho Cell Production

Mar 18 2026Newsfilter

MannKind CEO Buys Shares, Sempra Director Purchases Stock

Mar 12 2026NASDAQ.COM

MannKind CEO Acquires 100,000 Shares

Mar 11 2026seekingalpha

MannKind Presents New Data on Afrezza at Diabetes Conference

Mar 09 2026Newsfilter

MannKind Corp Reports Record Q4 Revenue and Strategic Developments

Mar 06 2026Yahoo Finance

MannKind Corporation Settles Remaining Convertible Notes

Mar 05 2026Newsfilter

MannKind Reports 2025 Financial Results with Strong Sales Growth

Feb 27 2026Benzinga

MannKind's Earnings Miss Expectations, Stock Drops

Feb 27 2026Fool

MannKind Reports Mixed Earnings, Stock Drops Over 7%

Feb 27 2026NASDAQ.COM

MannKind Corporation Reports Strong Q4 2025 Earnings and Growth Strategy

Feb 26 2026seekingalpha

MannKind Shares Plummet to New 52-Week Low Following Earnings Miss

Feb 26 2026seekingalpha

MannKind Q4 Earnings Beat Expectations with Revenue Growth

Feb 26 2026seekingalpha

United Therapeutics' New Drug Plans Pressure Partner and Rival Stocks

Feb 25 2026seekingalpha

MannKind Faces Uncertainty Over Tyvaso DPI Royalties

Feb 25 2026stocktwits